Annual Shareholders Equity
$109.46 M
-$17.29 M-13.64%
December 31, 2023
Summary
- As of February 8, 2025, AVTE annual stockholders equity is $109.46 million, with the most recent change of -$17.29 million (-13.64%) on December 31, 2023.
- During the last 3 years, AVTE annual shareholders equity has risen by +$122.80 million (+920.26%).
- AVTE annual shareholders equity is now -36.52% below its all-time high of $172.42 million, reached on December 31, 2021.
Performance
AVTE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$80.49 M
-$13.90 M-14.73%
September 30, 2024
Summary
- As of February 8, 2025, AVTE quarterly stockholders equity is $80.49 million, with the most recent change of -$13.90 million (-14.73%) on September 30, 2024.
- Over the past year, AVTE quarterly shareholders equity has dropped by -$28.96 million (-26.46%).
- AVTE quarterly shareholders equity is now -55.24% below its all-time high of $179.85 million, reached on September 30, 2021.
Performance
AVTE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AVTE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -13.6% | -26.5% |
| 3 y3 years | +920.3% | -26.5% |
| 5 y5 years | +3104.6% | -26.5% |
AVTE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -36.5% | at low | -53.3% | at low |
| 5 y | 5-year | -36.5% | +920.3% | -55.2% | +473.0% |
| alltime | all time | -36.5% | +920.3% | -55.2% | +473.0% |
Aerovate Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $80.49 M(-14.7%) |
| Jun 2024 | - | $94.40 M(+3.8%) |
| Mar 2024 | - | $90.90 M(-16.9%) |
| Dec 2023 | $109.46 M(-13.6%) | $109.46 M(-12.9%) |
| Sep 2023 | - | $125.72 M(-11.4%) |
| Jun 2023 | - | $141.93 M(+25.5%) |
| Mar 2023 | - | $113.09 M(-10.8%) |
| Dec 2022 | $126.74 M | $126.74 M(-8.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $139.14 M(-7.9%) |
| Jun 2022 | - | $151.05 M(-6.7%) |
| Mar 2022 | - | $161.95 M(-6.1%) |
| Dec 2021 | $172.42 M(-1392.1%) | $172.42 M(-4.1%) |
| Sep 2021 | - | $179.85 M(-933.5%) |
| Jun 2021 | - | -$21.58 M(+33.9%) |
| Mar 2021 | - | -$16.11 M(+20.8%) |
| Dec 2020 | -$13.34 M(+266.3%) | -$13.34 M |
| Dec 2019 | -$3.64 M | - |
FAQ
- What is Aerovate Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual shareholders equity year-on-year change?
- What is Aerovate Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly shareholders equity year-on-year change?
What is Aerovate Therapeutics annual stockholders equity?
The current annual shareholders equity of AVTE is $109.46 M
What is the all time high annual shareholders equity for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual stockholders equity is $172.42 M
What is Aerovate Therapeutics annual shareholders equity year-on-year change?
Over the past year, AVTE annual stockholders equity has changed by -$17.29 M (-13.64%)
What is Aerovate Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of AVTE is $80.49 M
What is the all time high quarterly shareholders equity for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly stockholders equity is $179.85 M
What is Aerovate Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, AVTE quarterly stockholders equity has changed by -$28.96 M (-26.46%)